Managing Biotechnology: From Science to Market in the Digital Age

Biopharma companies are facing increasing development costs and aging demographics, while digital technologies have altered the healthcare industry. This book provides a comprehensive overview of the new business context and marketing models for biotech companies, analyzing the strategies and key success factors for financing, developing, and commercializing novel therapeutic products. It is written by two experts and informed by extensive input by senior biotech executives and leading consultancies.

\n Format: Paperback / softback
\n Length: 320 pages
\n Publication date: 08 December 2017
\n Publisher: John Wiley and Sons Ltd
\n

Biotechnology has emerged as a pivotal force in the realm of human healthcare, driven by significant advancements in the field. However, as the biopharma industry continues to expand its reach, it faces a convergence of challenges. On the one hand, the rising development costs are juxtaposed with the aging demographics and cost-containment policies of private and public payers. Simultaneously, the emergence and increasing affordability of sophisticated digital technologies have transformed numerous industries, including healthcare. The arrival of new information technology (infotech) companies in the healthcare landscape presents both opportunities and complexities for the biopharma business model. To harness the potential of new digital technologies from research and development to commercialization, industry leaders must embrace innovative business models, cultivate robust digital and data capabilities, and forge strategic partnerships with innovators and payers across the globe.

This comprehensive book, authored by two esteemed experts with extensive experience in the field, offers a thorough examination of the new business context and marketing models for biotech companies. Drawing upon extensive input from senior biotech executives and leading consultancies servicing the industry, it delves into the strategies and critical success factors for financing, developing, and commercializing novel therapeutic products. The book also provides valuable insights into engagement strategies with patients, physicians, and healthcare payers, contributing to the better understanding and advancement of the biotech sector.

Throughout the book, case studies serve as valuable resources for researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals engaged in the biotech industry. These case studies provide insights, ideas, and models that can assist professionals in navigating the complex landscape and making informed decisions.

In conclusion, the convergence of challenges and opportunities in the biopharma industry has necessitated a shift towards innovative business models and digital technologies. This book serves as a valuable guide for industry leaders, providing a comprehensive overview of the new business context and marketing models for biotech companies. By embracing these strategies, professionals can navigate the complexities of the industry and drive sustainable growth and success.

\n Weight: 500g\n
Dimension: 155 x 228 x 16 (mm)\n
ISBN-13: 9781119216179\n \n